| Primary |
| Basal Cell Carcinoma |
28.1% |
| Actinic Keratosis |
19.1% |
| Anogenital Warts |
11.3% |
| Skin Papilloma |
8.2% |
| Precancerous Cells Present |
5.9% |
| Skin Cancer |
5.1% |
| Squamous Cell Carcinoma |
3.5% |
| Precancerous Skin Lesion |
3.1% |
| Bowen's Disease |
1.6% |
| Condyloma Acuminatum |
1.6% |
| Skin Disorder |
1.6% |
| Skin Lesion |
1.6% |
| Squamous Cell Carcinoma Of Skin |
1.6% |
| Biopsy |
1.2% |
| Hyperkeratosis |
1.2% |
| Hypertension |
1.2% |
| Infection |
1.2% |
| Molluscum Contagiosum |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Cheilitis |
0.8% |
|
| Pyrexia |
13.0% |
| Weight Decreased |
10.9% |
| Vision Blurred |
8.7% |
| Urticaria |
7.6% |
| Wrong Technique In Drug Usage Process |
6.5% |
| Lymphadenopathy |
5.4% |
| Myocardial Infarction |
4.3% |
| Scab |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Swelling |
4.3% |
| Nausea |
3.3% |
| Swollen Tongue |
3.3% |
| Thermal Burn |
3.3% |
| Tinnitus |
3.3% |
| Treatment Noncompliance |
3.3% |
| Upper Respiratory Tract Infection |
3.3% |
| Vertigo |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Application Site Erythema |
2.2% |
| Dizziness |
2.2% |
|
| Secondary |
| Actinic Keratosis |
27.8% |
| Depression |
13.3% |
| Basal Cell Carcinoma |
10.0% |
| Anogenital Warts |
5.6% |
| Drug Use For Unknown Indication |
4.4% |
| Precancerous Skin Lesion |
4.4% |
| Skin Cancer |
4.4% |
| Sunburn |
4.4% |
| Precancerous Cells Present |
3.3% |
| Sciatica |
3.3% |
| T-cell Lymphoma |
3.3% |
| Breast Cancer |
2.2% |
| Cyst |
2.2% |
| Erectile Dysfunction |
2.2% |
| Pain |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Abscess |
1.1% |
| Anxiety |
1.1% |
| Application Site Infection |
1.1% |
| Atrial Fibrillation |
1.1% |
|
| Sunburn |
13.3% |
| Paraesthesia |
10.0% |
| Drug Ineffective |
6.7% |
| Myocardial Infarction |
6.7% |
| Pleural Effusion |
6.7% |
| Skin Reaction |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Anaphylactic Reaction |
3.3% |
| Application Site Discolouration |
3.3% |
| Application Site Erythema |
3.3% |
| Condition Aggravated |
3.3% |
| Erythema Multiforme |
3.3% |
| Eye Pain |
3.3% |
| Feeling Hot |
3.3% |
| Hydrocephalus |
3.3% |
| Intestinal Obstruction |
3.3% |
| Lung Disorder |
3.3% |
| Ocular Icterus |
3.3% |
| Pain In Jaw |
3.3% |
| Pneumonia |
3.3% |
|
| Concomitant |
| Hiv Infection |
28.5% |
| Pain |
7.3% |
| Eczema |
6.6% |
| Product Used For Unknown Indication |
6.4% |
| Anxiety |
5.8% |
| Contraception |
5.8% |
| Menopause |
5.3% |
| Hypertension |
4.2% |
| Anogenital Warts |
3.5% |
| Depression |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Menopausal Symptoms |
2.7% |
| Polyarthritis |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Diarrhoea |
2.4% |
| Menstrual Cycle Management |
2.2% |
| Pleurisy |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hyperlipidaemia |
2.0% |
| Skin Papilloma |
2.0% |
|
| Vaginal Haemorrhage |
14.8% |
| Viral Pharyngitis |
12.3% |
| Weight Decreased |
9.9% |
| Death |
4.9% |
| Tooth Extraction |
4.9% |
| Varices Oesophageal |
4.9% |
| Ventricular Septal Defect |
4.9% |
| Abdominal Pain |
3.7% |
| Cholelithiasis |
3.7% |
| Deep Vein Thrombosis |
3.7% |
| Organising Pneumonia |
3.7% |
| Pain |
3.7% |
| Pneumonia |
3.7% |
| Pulmonary Embolism |
3.7% |
| Pulmonary Infarction |
3.7% |
| Wound Treatment |
3.7% |
| Biliary Colic |
2.5% |
| Blood Creatine Phosphokinase Increased |
2.5% |
| Blood Glucose Increased |
2.5% |
| Brain Stem Haemorrhage |
2.5% |
|
| Interacting |
|
|
